Immediate Impact

1 from Science/Nature 50 standout
Sub-graph 1 of 25

Citing Papers

Emerging Delivery Systems for Enabling Precision Nucleic Acid Therapeutics
2025 Standout
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
2 intermediate papers

Works of Kazuyuki Numakura being referenced

Avelumab plus axitinib vs sunitinib for advanced renal cell carcinoma: Japanese subgroup analysis from JAVELIN Renal 101
2019
Inhibition of the RANK/RANKL signaling with osteoprotegerin prevents castration-induced acceleration of bone metastasis in castration-insensitive prostate cancer
2017

Author Peers

Author Last Decade Papers Cites
Kazuyuki Numakura 632 380 435 441 149 1.7k
Pascal Eschwège 821 541 294 535 126 2.0k
Ryoichi Imamura 260 343 311 279 133 1.3k
Hassan Izzedine 697 249 504 397 91 2.0k
Tatsuya Takayama 721 633 439 581 127 2.0k
Masayoshi Okumi 447 774 436 365 183 2.0k
Arnaldo Figueiredo 512 511 235 335 143 1.8k
François Glowacki 180 235 145 568 81 1.7k
Hayakazu Nakazawa 470 551 691 336 63 1.7k
Christoph Schwarz 278 510 263 472 66 1.7k
F Mampaso 281 262 241 386 90 2.0k

All Works

Loading papers...

Rankless by CCL
2026